Thromboxane inhibition with burimamide
US4228176A · kind A · utility
1Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 1979 |
| Grant date | Oct 14, 1980 |
| Priority date | — |
| Expiry date | Apr 9, 1999 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/415
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure describes a method for selectively inhibiting thromboxane biosynthesis with Burimamide, a compound previously known to be a histamine H.sub.2 -receptor blocker. The discovery is useful in the treatment of a number of cardiovascular and inflammatory diseases in which thromboxane biosynthesis is involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.